| |
| |
|
| Insider
Information: |
Norry Elliot |
| Relationship: |
Chief Medical Officer |
| City: |
Philadelphia |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
19,257 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$20,701 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
19,257 |
|
|
| Total
Value |
$20,701 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adaptimmune Therapeutics PLC |
ADAP |
Chief Medical Officer |
2024-01-17 |
19,257 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical Officer |
• – – |
2024-01-17 |
4 |
S |
$0.67 |
$12,300 |
D/D |
(18,276) |
19,257 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical Officer |
• – – |
2024-01-16 |
4 |
S |
$0.79 |
$1,807 |
D/D |
(2,287) |
3,363 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical Officer |
• – – |
2024-01-12 |
4 |
S |
$0.85 |
$6,661 |
D/D |
(7,799) |
11,841 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical Officer |
• – – |
2024-01-11 |
4 |
S |
$0.84 |
$3,354 |
D/D |
(4,009) |
6,104 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical Officer |
• – – |
2023-01-17 |
4 |
S |
$1.86 |
$4,011 |
D/D |
(2,159) |
3,491 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical Officer |
• – – |
2023-01-12 |
4 |
S |
$1.71 |
$12,708 |
D/D |
(7,449) |
12,191 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical Officer |
• – – |
2023-01-11 |
4 |
S |
$1.75 |
$6,713 |
D/D |
(3,843) |
6,270 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical Officer |
• – – |
2023-01-04 |
4 |
S |
$1.69 |
$1,484 |
D/D |
(876) |
1,361 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical Officer |
• – – |
2022-01-18 |
4 |
S |
$3.19 |
$6,770 |
D/D |
(2,121) |
3,529 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical Officer |
• – – |
2022-01-12 |
4 |
S |
$3.54 |
$3,027 |
D/D |
(854) |
1,383 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical Officer |
• – – |
2022-01-11 |
4 |
S |
$3.56 |
$13,409 |
D/D |
(3,770) |
6,343 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical Officer |
• – – |
2022-01-04 |
4 |
S |
$4.06 |
$3,451 |
D/D |
(849) |
1,388 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical Officer |
• – – |
2021-01-19 |
4 |
S |
$5.67 |
$11,968 |
D/D |
(2,111) |
3,539 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical Officer |
• – – |
2021-01-12 |
4 |
S |
$6.15 |
$5,174 |
D/D |
(841) |
1,396 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical Officer |
• – – |
2021-01-04 |
4 |
S |
$5.33 |
$4,502 |
D/D |
(845) |
1,392 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical Officer |
• – – |
2020-01-14 |
4 |
S |
$5.13 |
$4,678 |
D/D |
(911) |
1,326 |
0 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Chief Medical OfficerOfficer |
• – – |
2020-01-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,679 |
|
% |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
